Personal profile
Education/Academic qualification
Post Doctoral Fellow, University Of Pennsylvania
1981
Residency, Peter Bent Brigham Hospital, Boston, Massachusetts
1978
Doctor of Medicine, Harvard University
1976
Bachelor of Arts, Harvard University
1970
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Projects & Grants
- 19 Finished
-
13-NHL-21-JJ:(PCI-32765FLR3001) Ibrutinib combined with either BR or R-CHOP for relapsed iNHL
Fleischman, R. (PI)
Janssen Research and Development LLC
5/19/14 → 5/31/16
Project: Research project
-
14-HEM-05-SA (TED12414) Extension study for patients benefiting from treatment on ARD12130
Fleischman, R. (PI)
1/1/14 → 10/31/14
Project: Research project
-
12-NHL-18-JJ (PCI-32765MCL3002) Bendamustine-Rituximab +/- Ibrutinib for newly diagnosed Mantle Cell Lymphoma (SHINE)
Fleischman, R. (PI) & Hayslip, J. (Former PI)
Janssen Research and Development LLC
5/10/13 → 7/31/24
Project: Research project
-
12NHL14JJ BTK Inhibitor+Ibrutinib in Patients with Mantle Cell Lymphoma who Progress After Bortezomib
Fleischman, R. (PI) & Hayslip, J. (Former PI)
Janssen Research and Development LLC
8/1/12 → 3/30/16
Project: Research project
-
A Phase 3 Open-Label Randomized Study to Compare the Efficacy And Safety of Rituximab Plus lenalidomide (CC-5013) versus Rituximab Plus Chemotherapy in Subjects with Previously Untreated Follicular Lymphoma
Fleischman, R. (PI), Monohan, G. (CoI), Hayslip, J. (Former PI) & Shakil, S. (Former CoI)
4/12/12 → 8/21/23
Project: Research project
-
Measurable Residual Disease–Guided Therapy for Chronic Lymphocytic Leukemia
Fleischman, R. A., Dec 4 2025, In: New England Journal of Medicine. 393, 22, p. 2279 1 p.Research output: Contribution to journal › Letter › peer-review
-
Interleukin-10 suppression enhances T-cell antitumor immunity and responses to checkpoint blockade in chronic lymphocytic leukemia
Rivas, J. R., Liu, Y., Alhakeem, S. S., Eckenrode, J. M., Marti, F., Collard, J. P., Zhang, Y., Shaaban, K. A., Muthusamy, N., Hildebrandt, G. C., Fleischman, R. A., Chen, L., Thorson, J. S., Leggas, M. & Bondada, S., Nov 2021, In: Leukemia. 35, 11, p. 3188-3200 13 p.Research output: Contribution to journal › Article › peer-review
Open Access53 Scopus citations -
Essential Thrombocythemia
Fleischman, R. A., Mar 19 2020, In: New England Journal of Medicine. 382, 12, p. E21Research output: Contribution to journal › Letter › peer-review
1 Scopus citations -
Chronic lymphocytic leukemia-derived IL-10 suppresses antitumor immunity
Alhakeem, S. S., McKenna, M. K., Oben, K. Z., Noothi, S. K., Rivas, J. R., Hildebrandt, G. C., Fleischman, R. A., Rangnekar, V. M., Muthusamy, N. & Bondada, S., Jun 15 2018, In: Journal of Immunology. 200, 12, p. 4180-4189 10 p.Research output: Contribution to journal › Article › peer-review
Open Access49 Scopus citations -
Novel role of prostate apoptosis response-4 tumor suppressor in B-cell chronic lymphocytic leukemia
McKenna, M. K., Noothi, S. K., Alhakeem, S. S., Oben, K. Z., Greene, J. T., Mani, R., Perry, K. L., Collard, J. P., Rivas, J. R., Hildebrandt, G. C., Fleischman, R. A., Durbin, E. B., Byrd, J. C., Wang, C., Muthusamy, N., Rangnekar, V. M. & Bondada, S., Jun 28 2018, In: Blood. 131, 26, p. 2943-2954 12 p.Research output: Contribution to journal › Article › peer-review
Open Access13 Scopus citations